A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients ...
A recent retrospective study identifies key factors contributing to high failure rates of clinical trials evaluating treatments for head and neck squamous cell carcinoma.
MSK radiation oncologist Dr. Nadeem Riaz and colleagues discovered that bacteria inside tumors can undermine the effects of immunotherapy. In cancer research, failure can lead to an important ...
This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...
In more recent decades, HPV has been shown as a risk factor for developing head and neck cancer. Head and neck cancer covers everything from throat, tongue, and tonsil cancer to laryngeal, mouth, and ...
Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain head and neck cancers from returning. Continuous use of Keytruda—both ...
Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells ...
A clinical-stage biopharmaceutical company is testing a new targeted cancer treatment based on the notion that solid tumors can be compelled to develop their own chemotherapy and self-destruct. In PNP ...
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...
The Head and Neck Cancer Timely Presentation Campaign launches in Birkenhead, urging early detection with self-checks for men at high risk ...
Most Americans drink coffee or tea — both can help with mood, concentration, metabolism, weight maintenance and high blood sugar. A new scientific review finds that grabbing a cup of either brew can ...
The market opportunities in the PD-1 Resistant Head and Neck Cancer sector include the rising need for salvage therapies due to resistance to standard treatments, the proliferation of next-gen ...